Cresco Labs (CRLBF) Long-Term Deferred Tax (2019 - 2026)

Cresco Labs' Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $13.6 million for Q1 2026.

• Quarterly Long-Term Deferred Tax rose 5.58% year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 5.58% YoY) and the FY2025 annual result came in at $13.5 million, up 2.85% from the prior year.
• Long-Term Deferred Tax was $13.6 million for Q1 2026 at Cresco Labs, up from $13.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $17.6 million in Q2 2024 and bottomed at $26000.0 in Q4 2022.
• A 5-year average of $10.7 million and a median of $12.4 million in 2025 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2022 — Long-Term Deferred Tax slumped 99.6% — and 2023, when it soared 44311.54%.
• Cresco Labs' Long-Term Deferred Tax stood at $26000.0 in 2022, then surged by 44311.54% to $11.5 million in 2023, then advanced by 13.68% to $13.1 million in 2024, then advanced by 2.85% to $13.5 million in 2025, then gained by 1.09% to $13.6 million in 2026.
• Business Quant data shows CRLBF's Long-Term Deferred Tax at $13.6 million in Q1 2026, $13.5 million in Q4 2025, and $12.4 million in Q3 2025.